Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02546011 · ClinicalTrials.gov registry record
The Monica Fetal Heart Monitor
A clinical trial, sponsored by St. Louis University.
- Completed
- Registry status
- 36
- Enrollment target
NCT02546011: Completed study, sponsored by St. Louis University.
NCT02546011 is a clinical trial that has completed, run by St. Louis University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02546011 has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The goal of this study is to compare the amount of time that the fetal heart tones are traced in babies just at or beyond viability using a traditional device compared to the Monica device.
Primary Outcome
This study is to compare the amount of time that the fetal heart tones are traced in babies just at or beyond viability using a traditional device compared to the Monica device.
Interventions
- OTHER Fetal Heart Rate Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-07 |
What the finished NCT02546011 record still lists
NCT02546011 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fetal Heart Rate Monitor is the first listed.
NCT02546011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02546011 about?
NCT02546011 is a clinical study titled "The Monica Fetal Heart Monitor". The goal of this study is to compare the amount of time that the fetal heart tones are traced in babies just at or beyond viability using a traditional device compared to the Monica device.
What is the current status of trial NCT02546011?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2014-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02546011?
The interventions under investigation include: Fetal Heart Rate Monitor (OTHER).
Who is sponsoring clinical trial NCT02546011?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia